Puma Biotech (PBYI) Tops Q1 EPS by 89c

Puma Biotech (NASDAQ: PBYI) reported Q1 EPS of $0.21, $0.89 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $99.1 million versus the consensus estimate of $67.25 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
• OceanaGold to acquire Ausgold in a deal valued at A$776M